CN2885303Y - Intracavity prostate therapeutic equipment - Google Patents
Intracavity prostate therapeutic equipment Download PDFInfo
- Publication number
- CN2885303Y CN2885303Y CN 200620103463 CN200620103463U CN2885303Y CN 2885303 Y CN2885303 Y CN 2885303Y CN 200620103463 CN200620103463 CN 200620103463 CN 200620103463 U CN200620103463 U CN 200620103463U CN 2885303 Y CN2885303 Y CN 2885303Y
- Authority
- CN
- China
- Prior art keywords
- ring
- cavity
- therapeutic
- phosphorus
- intracavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Radiation-Therapy Devices (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The utility model relates an intracavity prostate gland therapeutic equipment, wherein, the inner hollow guide conduit provide three mutual separated and not interconnected cavity of septum as ureteromy cavity, administer medicine cavity and aeration cavity, an ureteromy hole and phosphorus 32 therapeutic ring in the back are equipped in the front of the hollow guide conduit, a cartridge air sac is provided on the outer rim of the ureteromy hole and phosphorus 32 therapeutic ring, the end of aeration cavity link with the sealing cartridge air sac by the abscess, a cartridge protection cover is provided on the outer rim of the therapeutic ring, the therapeutic ring which in the end of administer medicine cavity provide a permeability administer hole with the outer wall. The utility model employs therapeutic equipment which is made of soft dip non-toxicity environmental protection material to break-in male patients urinary easily and indolence, aerate or water-filling cartridge air sac can pinpoint the therapeutic ring in the prostate gland lesion position, radioactive nuclide, anti-inflammatory or thin directing line can be put in through the administer medicine cavity and the radiation, anti-inflammatory or ion-introduction therapy can be done. The half-decay time of phosphorus 32 is only 14 days, thereby, protections, safekeeping and waste processing are convenient.
Description
Technical field
This utility model relates to a kind of medical apparatus and instruments, particularly a kind of intracavity prostate treatment device.
Background technology
Hyperplasia of prostate is the commonly encountered diseases of male, particularly elderly men, for a long time, and the simple and easy to do Therapeutic Method beyond people are devoted to seek to perform the operation.The urethra type nucleic prostatic hyperplasia therapeutic instrument that nineteen nineties emerges comprises a rifle shape treatment head, and it is that a head is provided with the hollow metallic conduit in urethral catheterization hole, and is with the radionuclide therapy ring; Treatment head insertion prostatic hyperplasia patient's urethra, the urethral catheterization hole enters bladder, and the radionuclide therapy ring enters and aim at the prostatic lesion position, carries out radiotherapy by the radioactive source on the radionuclide therapy ring.This non-surgical treatment has certain curative effect, but has deficiency: 1. hard metal treatment head inserts male patient's a urethra, and relatively more difficult, the patient agonizes; 2. the degree of depth of treatment head insertion is difficult to grasp, and is difficult to " radionuclide therapy ring " accurately is positioned the prostatic lesion position of bladder porch; 3. the radioactive source that adopts now mostly is strontium 90, and its half-life is 28 years, need protect and keep properly at the radioactive source of usefulness, and their garbage is more wanted safe disposal, arbitrarily abandons and will cause long-term, serious nuclear pollution consequence.
Summary of the invention
The purpose of this utility model provides a kind of with prostate treatment device in the soft flexible chamber of thin film positioning gasbag.
This utility model is realized by following technical proposal: a kind of intracavity prostate treatment device, be provided with mutual isolation, mutual disconnected urethral catheterization chamber, administration chamber and three separate spaces of venting cavity in the hollow conduit made from soft flexible asepsis environment-protecting material, their rear end is respectively equipped with joint; Be provided with urethral catheterization hole and the treatment ring that is positioned at thereafter at the hollow conduit front end.The treatment ring is adsorbed with phosphorus 32, facts have proved: the β ray that phosphorus 32 discharges can be treated prostatic hyperplasia effectively; The available soft flexible material that is adsorbed with phosphorus 32 is close to position, the replacement therapy ring of treatment ring, also can directly smear phosphorus 32 on the treatment ring position of hollow conduit.Outer rim between urethral catheterization hole and treatment ring is provided with the thin film air bag, and the end of venting cavity is communicated with the thin film air bag of sealing by pore, and the outer rim of encircling in treatment is provided with the thin film protective cover, is used for protecting the treatment ring of having smeared phosphorus 32; Position at the end in administration chamber treatment ring is provided with the dosing holes penetrating with outer wall.
The beneficial effects of the utility model are:
1. phosphorus-32 β ray intracavity prostate treatment the device made from soft flexible asepsis environment-protecting material inserts male patient's urethra, than being easier to patient's no pain.
2. the thin film air bag of inflation or water-filling can accurately be positioned the treatment ring that is adsorbed with phosphorus 32 the prostatic lesion position of bladder porch, helps improving therapeutic effect and efficient, and difficulty simplifies the operation.
3. the β ray of phosphorus 32 releases can be treated prostatic hyperplasia, the organ that is not detrimental to health again effectively; The half-life of phosphorus 32, the disposal of protection, keeping and garbage thereof was all easier in order to have only 14 days.
4. can put into active nucleus through the administration chamber, press close to the prostatic lesion position, carry out radiotherapy; Also can put into the antibiotic medicine, anti-inflammatory treatment is carried out at the prostatic lesion position; Also can put into a thin wire, iontophoresis is carried out at the prostatic lesion position.
5. patient's prostate size, hardness vary with each individual, and cost of the present utility model is lower, can be according to each patient's prostate size, the special-purpose therapeutic apparatus of hardness customization individual; Not only the suitability with patient's prostate size is good, can stop again to use public therapeutic apparatus, causes pathophorous drawback.
Description of drawings
Below in conjunction with drawings and Examples this utility model is further specified.
Fig. 1 is a structural representation of the present utility model.
Fig. 2 is the A-A cutaway view of Fig. 1.
When being the contraction of thin film air bag, inserts Fig. 3 the sketch map of body of prostate from urethra.
The specific embodiment
During treatment, take out soft flexible latex intracavity prostate treatment device vacuum-packed or after sterilization, the treatment ring 5 of smearing phosphorus 32 or will be adsorbed with phosphorus 32 on treatment ring 5 is inserted in the thin film protective cover 4 of therapeutic apparatus end.Soft flexible therapeutic apparatus is slowly inserted male patient's urethra, make the thin film air bag 7 that is in soft state enter bladder 10 fully.Inflate to the thin film air bag 7 of sealing through venting cavity 3, pore 9 with syringe, it is opened, gently draw therapeutic apparatus backward, make the thin film air bag of inflation accurately be positioned the bladder outlet place, and can not deviate from; Meanwhile, the treatment ring that is adsorbed with phosphorus 32 also accurately is positioned the prostatic lesion position of bladder porch.Bladder 10 inner products urine is discharged by the urethral catheterization hole 8 and the urethral catheterization chamber 1 that are positioned at thin film air bag 7 tops; After finish a course of treatment, pull out catheter and syringe, the gas in the thin film air bag 7 is in soft state after discharging, and gently draws just backward and can take out therapeutic apparatus.
2. 1 kinds of phosphorus-32 of embodiment β ray intracavity prostate treatment device, the available soft flexible material that is adsorbed with phosphorus 32 are close to the position of treatment ring, alternate embodiment 1 described treatment ring.
3. 1 kinds of phosphorus-32 of embodiment β ray intracavity prostate treatment device can directly be smeared phosphorus 32, alternate embodiment 1 described treatment ring on the treatment ring position of embodiment 1 described hollow conduit.
4. 1 kinds of phosphorus-32 of embodiment β ray intracavity prostate treatment device, available syringe, opens it to thin film gas [water] capsule (7) water filling that seals through ventilation [water] chamber (3), hole (9).
Claims (4)
1. intracavity prostate treatment device; form by hollow conduit, urethral catheterization hole and treatment ring; it is characterized in that: be provided with mutual isolation, mutual disconnected urethral catheterization chamber (1), administration chamber (2) and (3) three separate spaces of venting cavity in the hollow conduit; be provided with urethral catheterization hole (8) and be positioned at thereafter treatment ring (5) at the hollow conduit front end; outer rim between them is provided with thin film air bag (7), and the outer rim of encircling (5) in treatment is provided with thin film protective cover (4).
2. intracavity prostate treatment device according to claim 1 is characterized in that: the position at the end of administration chamber (2) treatment ring is provided with the dosing holes penetrating with outer wall (6).
3. intracavity prostate treatment device according to claim 1 is characterized in that: the end of venting cavity (3) is communicated with by the thin film air bag (7) of pore (9) with sealing.
4. intracavity prostate treatment device according to claim 1 is characterized in that: the rear end of urethral catheterization chamber (1), administration chamber (2) and venting cavity (3) is respectively equipped with joint.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200620103463 CN2885303Y (en) | 2006-05-09 | 2006-05-09 | Intracavity prostate therapeutic equipment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200620103463 CN2885303Y (en) | 2006-05-09 | 2006-05-09 | Intracavity prostate therapeutic equipment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN2885303Y true CN2885303Y (en) | 2007-04-04 |
Family
ID=37960396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200620103463 Expired - Fee Related CN2885303Y (en) | 2006-05-09 | 2006-05-09 | Intracavity prostate therapeutic equipment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN2885303Y (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126230A (en) * | 2015-08-19 | 2015-12-09 | 陕西远光高科技有限公司 | Urinary catheter having anti-clogging and anti-inflammatory functions |
| CN105413018A (en) * | 2015-12-31 | 2016-03-23 | 臧家红 | Cavity guiding interventional treatment device for prostate disease |
-
2006
- 2006-05-09 CN CN 200620103463 patent/CN2885303Y/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126230A (en) * | 2015-08-19 | 2015-12-09 | 陕西远光高科技有限公司 | Urinary catheter having anti-clogging and anti-inflammatory functions |
| CN105126230B (en) * | 2015-08-19 | 2020-02-18 | 陕西远光高科技有限公司 | Catheter with prevent blockking up and anti-inflammation function |
| CN105413018A (en) * | 2015-12-31 | 2016-03-23 | 臧家红 | Cavity guiding interventional treatment device for prostate disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5007897A (en) | Drug delivery catheter | |
| US7534202B2 (en) | System and method for high dose rate radiation intracavitary brachytherapy | |
| GB2415907A (en) | A radiotherapy device for treating cancers in viscous organs such as the bladder | |
| CN2885303Y (en) | Intracavity prostate therapeutic equipment | |
| EP1551355B1 (en) | A device for delivering fluid to the bladder | |
| CN201871125U (en) | Back-installed source applicator of esophageal cancer | |
| CN201006055Y (en) | Biliary tract supporting inside and outside conduction and continuous intracavity near-range radiotheraphy combination units | |
| CN207545613U (en) | Inflatable medical anal canal | |
| Smit et al. | An indwelling intrauterine tube to facilitate intracavitary radiotherapy of carcinoma of the cervix | |
| CN1537647A (en) | Tumour close internal rediation therapy device presetted in operation | |
| CN208641492U (en) | A kind of detachable embedding medical biliary stent | |
| CN207384587U (en) | A kind of catheter | |
| CN2834608Y (en) | Radioactive particle implanter | |
| CN111359030A (en) | Biliary tract close-range irradiation drainage device for 3D personalized printing under assistance of TPS (thermoplastic polyurethane) | |
| CN208448388U (en) | A kind of novel catheter apparatus | |
| CN219539278U (en) | Recoverable double-saccule internal radiotherapy device | |
| CN214209116U (en) | Intubation type treatment device with replaceable treatment source | |
| Khan et al. | Transperineal percutaneous iridium-192 implant of the prostate | |
| CN218652704U (en) | Novel disposable catheter with anesthesia function | |
| CN218529564U (en) | Physical partition device for protecting adjacent organs during radiotherapy | |
| CN209490361U (en) | A kind of X-ray radiography Novel urethral catheter device | |
| CN218220811U (en) | Female reproductive system tumor intracavity radioactive particle treatment kit | |
| CN210750935U (en) | Portal vein cancer embolus and bile duct cancer embolus treatment assembly | |
| Middleton Jr et al. | Combined modality therapy with conservation of organ function in childhood genitourinary rhabdomyosarcoma | |
| CN2179155Y (en) | Permeating film bag inner cavity tumour treatment tube |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070404 |